Cargando…

ERK MAPK signaling pathway inhibition as a potential target to prevent autophagy alterations in Spinal Muscular Atrophy motoneurons

Spinal Muscular Atrophy (SMA) is a severe genetic neuromuscular disorder that occurs in childhood and is caused by misexpression of the survival motor neuron (SMN) protein. SMN reduction induces spinal cord motoneuron (MN) degeneration, which leads to progressive muscular atrophy and weakness. The l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sansa, Alba, Miralles, Maria P., Beltran, Maria, Celma-Nos, Ferran, Calderó, Jordi, Garcera, Ana, Soler, Rosa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076363/ https://www.ncbi.nlm.nih.gov/pubmed/37019880 http://dx.doi.org/10.1038/s41420-023-01409-x

Ejemplares similares

Survival motor neuron protein and neurite degeneration are regulated by Gemin3 in spinal muscular atrophy motoneurons
por: Miralles, Maria P., et al.
Publicado: (2022)

Spinal Muscular Atrophy autophagy profile is tissue-dependent: differential regulation between muscle and motoneurons
por: Sansa, Alba, et al.
Publicado: (2021)

Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice
por: de la Fuente, Sandra, et al.
Publicado: (2018)

Notch Signaling Pathway Is Activated in Motoneurons of Spinal Muscular Atrophy
por: Caraballo-Miralles, Víctor, et al.
Publicado: (2013)

Inhibition of autophagy delays motoneuron degeneration and extends lifespan in a mouse model of spinal muscular atrophy
por: Piras, Antonio, et al.
Publicado: (2017)

Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models
por: de la Fuente, Sandra, et al.
Publicado: (2020)

Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro
por: Garcera, A, et al.
Publicado: (2013)

Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy()
por: Rusmini, Paola, et al.
Publicado: (2013)

R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy
por: Tejero, Rocio, et al.
Publicado: (2020)

Smn-Deficiency Increases the Intrinsic Excitability of Motoneurons
por: Arumugam, Saravanan, et al.
Publicado: (2017)

Defective Ca(2+) channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy
por: Jablonka, Sibylle, et al.
Publicado: (2007)

Nusinersen ameliorates motor function and prevents motoneuron Cajal body disassembly and abnormal poly(A) RNA distribution in a SMA mouse model
por: Berciano, María T., et al.
Publicado: (2020)

Autophagy inhibition: a new therapeutic target in spinal muscular atrophy
por: Piras, Antonio, et al.
Publicado: (2018)

Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
por: Gonçalves, Inês do Carmo G., et al.
Publicado: (2018)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Motoneuron deafferentation and gliosis occur in association with neuromuscular regressive changes during ageing in mice
por: Blasco, Alba, et al.
Publicado: (2020)

Smn, the spinal muscular atrophy–determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
por: Rossoll, Wilfried, et al.
Publicado: (2003)

Motoneuronal Spinal Circuits in Degenerative Motoneuron Disease
por: Falgairolle, Mélanie, et al.
Publicado: (2020)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

The Y172 Monoclonal Antibody Against p-c-Jun (Ser63) Is a Marker of the Postsynaptic Compartment of C-Type Cholinergic Afferent Synapses on Motoneurons
por: Gatius, Alaó, et al.
Publicado: (2020)

Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy
por: Lusakowska, Anna, et al.
Publicado: (2021)

Mitochondrial abnormalities in spinal and bulbar muscular atrophy
por: Ranganathan, Srikanth, et al.
Publicado: (2009)

Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
por: Gonçalves, Inês do Carmo G., et al.
Publicado: (2018)

Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
por: Gonçalves, Inês do Carmo G., et al.
Publicado: (2020)

The Burden of Spinal Muscular Atrophy on Informal Caregivers
por: Aranda-Reneo, Isaac, et al.
Publicado: (2020)

S289: PPP1R1B BINDS IRON REGULATORY PROTEINS AND MODULATES IRON CELLULAR CONTENT
por: Calvo López, Laura, et al.
Publicado: (2023)

Cardiac involvement in patients with Spinal Muscular Atrophies
por: Palladino, Alberto, et al.
Publicado: (2011)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gn7v0u9j3dd984jsi5t3s6qgnu